EyeGate completes direct public offering

EyeGate Pharmaceuticals Inc. (NASDAQ:EYEG), Waltham, Mass.
Business: Ophthalmic,

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE